Melanoma Matters
By Melanoma Matters Pod
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Melanoma Matters Pod
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 84
Description
From the UK to the USA - Melanoma Matters is on a mission!
Hosts James Larkin and Sapna Patel are spreading the word on melanoma, one podcast at a time. Tune in for a critical review of the literature and a discussion of how we incorporate the data into our practices...across the pond(s).
#MelanomaMatters video podcast
| Episode | Date |
|---|---|
|
Ep 81: IGNYTE trial (RP1 + nivo)
|
Feb 13, 2026 |
|
Ep 80: 2025 Holiday Special
|
Dec 30, 2025 |
|
Ep 79: coBRIM, COMBI-d 5-year follow-up
|
Dec 29, 2025 |
|
Ep 78 TRAILER: MEK inhibitor trials
|
Dec 29, 2025 |
|
Ep 78: MEK inhibitor trials (METRIC, NEMO, pimasertib)
|
Dec 29, 2025 |
|
Ep 77: Guest Merrick Ross
|
Dec 29, 2025 |
|
Ep 76: KEYNOTE 054 7-year follow-up
|
Dec 28, 2025 |
|
Ep 75: Immune-mediated Myocarditis
|
Dec 28, 2025 |
|
Ep 74: Best of ESMO 2025: Part 2 of 2
|
Dec 22, 2025 |
|
Ep 73: Best of ESMO 2025: Part 1 of 2
|
Nov 11, 2025 |
|
ESMO 2025 preview
|
Oct 22, 2025 |
|
Ep 72 TRAILER: Quiz show - new drug approvals in 2024
|
Oct 09, 2025 |
|
Ep 72: Quiz show - new drug approvals in 2024 (yes we're late...)
|
Oct 09, 2025 |
|
Ep 71: Women in Melanoma manuscript - now with a FACT CHECK!
|
Aug 02, 2025 |
|
Ep 70: Best of ASCO colon.... 2025 ;)
|
Jun 25, 2025 |
|
Ep 69: Guest Monty Pal
|
Jun 24, 2025 |
|
Ep 68: GDF-15 antibody GODFATHER trial
|
Jun 24, 2025 |
|
Ep 67: SITC white paper on ICI resistance
|
Apr 07, 2025 |
|
Ep 66: Ponsegromab for cancer cachexia
|
Mar 30, 2025 |
|
Ep 65: Opdivo Qvantig (subcutaneous formulation)
|
Mar 28, 2025 |
|
Ep 64: Guest Clare Turnbull Part 2
|
Mar 24, 2025 |
|
Ep 63: Guest Clare Turnbull Part 1
|
Mar 20, 2025 |
|
Ep 62: Post PD-1 studies
|
Mar 18, 2025 |
|
Ep 61: Guest Inge Marie Svane
|
Mar 12, 2025 |
|
Ep 60: Melanoma & Kidney Cancer w/ Mike Atkins
|
Mar 02, 2025 |
|
Ep 59: 2024 Reflections
|
Feb 13, 2025 |
|
Ep 58: Best of 2024: SMR
|
Dec 27, 2024 |
|
Ep 57: Best of 2024: ESMO
|
Dec 23, 2024 |
|
Ep 56: Best of 2024: ASCO
|
Dec 23, 2024 |
|
Ep 55: VIBE Intro - Give Us Your Feedback
|
Dec 12, 2024 |
|
Ep 54: All things MSLT with Mark Faries
|
Dec 10, 2024 |
|
Ep 53: Guest Toni Ribas
|
Dec 10, 2024 |
|
Ep 52: COLUMBUS 7-year follow-up
|
Nov 10, 2024 |
|
Ep 51: Exercise Oncology and TIL for CNS mets with Allison Betof Warner
|
Oct 14, 2024 |
|
Ep 50: ADAPT-IT Study
|
Oct 14, 2024 |
|
Ep 49: Melanoma Patient Network Europe with Bettina Ryll
|
Oct 14, 2024 |
|
Ep 48: CM 067 Final, 10-year analysis with Jedd Wolchok
|
Oct 14, 2024 |
|
Ep 47: TRICOTEL with Andreas Schmitt
|
Oct 14, 2024 |
|
Ep 46: Cemiplimab + Fianlimab (first report)
|
Oct 14, 2024 |
|
Ep 45: KEYNOTE 006 10 year follow-up
|
Oct 14, 2024 |
|
Ep 44: Treatment Beyond Progression
|
Oct 14, 2024 |
|
Ep 43: Mucosal Melanoma
|
Oct 14, 2024 |
|
Ep 42: RELATIVITY 020
|
Oct 14, 2024 |
|
Ep 41: Ipi 10 mg/kg v 3 mg/kg
|
Oct 14, 2024 |
|
Ep 40: CheckMate 238 Post-Recurrence Outcomes
|
Oct 14, 2024 |
|
Ep 39: LEAP 004 & 003
|
Oct 14, 2024 |
|
Ep 38: TIL v. Ipi
|
Oct 14, 2024 |
|
Ep 37: CheckMate 511
|
Oct 14, 2024 |
|
Ep 36: Indirect comparison CM 067 v RELA 047
|
Oct 14, 2024 |
|
Ep 35: End of Life care
|
Oct 14, 2024 |
|
Ep 34: CHOPIN & SCANDIUM trials for Uveal Melanoma
|
Oct 14, 2024 |
|
Ep 33: Percutaneous Hepatic Infusion for Uveal Melanoma
|
Oct 14, 2024 |
|
Ep 32: Ipi Nivo for Uveal Melanoma
|
Oct 14, 2024 |
|
Ep 31: Tebentafusp for Uveal Melanoma (Part Two)
|
Oct 14, 2024 |
|
Ep 30: Tebentafusp for Uveal Melanoma (Part One)
|
Oct 14, 2024 |
|
Ep 29: COMBI-AD long-term follow-up (10y)
|
Oct 14, 2024 |
|
Ep 28: RELATIVITY 048
|
Oct 14, 2024 |
|
Ep 27: NADINA in practice
|
Oct 14, 2024 |
|
Ep 26: NADINA w Christian Blank
|
Oct 14, 2024 |
|
Ep 25: Best of ASCO 2024 with Jeff Weber
|
Oct 14, 2024 |
|
Ep 24: SECOMBIT
|
Oct 14, 2024 |
|
Ep 23: DREAMSeq
|
Oct 14, 2024 |
|
Ep 22: Triplets for BRAF+ melanoma
|
Oct 14, 2024 |
|
Ep 21: Lifileucel
|
Oct 14, 2024 |
|
Ep 20: Neoadjuvant Nivolumab + Relatlimab
|
Oct 14, 2024 |
|
Ep 19: Single-dose of neoadjuvant pembro (UPenn study)
|
Oct 14, 2024 |
|
Ep 18: SD101 + Pembro
|
Oct 14, 2024 |
|
Ep 17: TVEC + Ipi
|
Oct 14, 2024 |
|
Ep 16: MASTERKEY 265
|
Oct 14, 2024 |
|
Ep 15: OPTiM
|
Oct 14, 2024 |
|
Ep 14: IMMUNED
|
Oct 14, 2024 |
|
Ep 13: SWOG S1801
|
Oct 14, 2024 |
|
Ep 12: PRADO
|
Oct 14, 2024 |
|
Ep 11: OpACIN-Neo
|
Oct 14, 2024 |
|
Ep 10: CheckMate 915
|
Oct 14, 2024 |
|
Ep 09: CheckMate 76K
|
Oct 14, 2024 |
|
Ep 08: KEYNOTE 716
|
Oct 14, 2024 |
|
Ep 07: KEYNOTE 054
|
Oct 14, 2024 |
|
Ep 06: CheckMate 238
|
Oct 14, 2024 |
|
Ep 05: SWOG S1404
|
Oct 14, 2024 |
|
Ep 04: EORTC 18071
|
Oct 14, 2024 |
|
Ep 03: CheckMate-204
|
Oct 14, 2024 |
|
Ep 02: RELATIVITY-047
|
Oct 14, 2024 |
|
Ep 01: CheckMate-067
|
Oct 14, 2024 |